Belluscura shares performance update
By HME News Staff
Updated 9:43 AM CDT, Mon June 17, 2024
LONDON and PLANO, Texas – Belluscura says sales of the X-PLOR portable oxygen concentrator in the United States were $820,000 in the three months to May 2024. The company says it recorded sales of $450,000 in May alone, its highest recorded monthly sales figure, across both direct-to-consumer and business-to-business channels. Belluscura says testing and validation of its DISCOV-R POC remains on schedule to ship in June. The company plans to initially sell the device through its DTC channel, then initiate sales through its B2B channel late in the third quarter. The company expects to announce audited results for the year ended Dec 2023 on or before June 28.
Comments